The impact of in-utero antipsychotic drug exposure on congenital malformations: An international cohort study
Krista F. Huybrechts(Brigham and Women's Hospital), Helle Kieler(Karolinska University Hospital), Loreen Straub(Brigham and Women's Hospital), Brian T. Bateman(Stanford Medicine), Mika Gissler(Finnish Institute for Health and Welfare), Kari Furu(Norwegian Institute of Public Health), Laura Pazzagli(Karolinska Institutet), Elizabeth A. Suarez(Rutgers, The State University of New Jersey), Jacqueline M. Cohen(Norwegian Institute of Public Health), Randi Selmer(Norwegian Institute of Public Health), Mette Nørgaard(Aarhus University Hospital), Maarit K. Leinonen(University of Helsinki), Pär Karlsson(Karolinska Institutet), Helga Zoëga(University of Iceland), Sonia Hernández–Dı́az(Harvard University)
STM:n Hallinnonalan avoin julkaisuarkisto (Julkari)
January 1, 2021
Cited by 0
Related Papers
ALKBH5 Is a Mammalian RNA Demethylase that Impacts RNA Metabolism and Mouse Fertility
|Molecular Cell|2012|3.7k
Association of Cardiometabolic Multimorbidity With Mortality
|JAMA|2015|1.2k
Association of Genetic and Environmental Factors With Autism in a 5-Country Cohort
|JAMA Psychiatry|2019|622
Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet—a population-based study
|The Lancet Oncology|2017|510
First-Trimester Use of Selective Serotonin-Reuptake Inhibitors and the Risk of Birth Defects
|New England Journal of Medicine|2007|497